Effective short-term treatment of generalized anxiety disorder with trifluoperazine.
J Clin Psychiatry
; 47(4): 170-4, 1986 Apr.
Article
in En
| MEDLINE
| ID: mdl-3514583
ABSTRACT
The effectiveness of trifluoperazine in daily doses of 2 to 6 mg in the short-term treatment of generalized anxiety disorder was evaluated in 415 outpatients in a double-blind, placebo-controlled, multicenter trial. Efficacy and side effects were assessed by a number of psychiatric rating scales for anxiety. All efficacy measurements of anxiety were significantly improved (p less than .001) with trifluoperazine compared to placebo by the end of the study. The side effects profile of trifluoperazine and placebo were similar during the 4-week treatment period.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Anxiety Disorders
/
Trifluoperazine
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Psychiatry
Year:
1986
Type:
Article